ADC Therapeutics SA
NYSE:ADCT
ADC Therapeutics SA
Long-Term Investments
ADC Therapeutics SA
Long-Term Investments Peer Comparison
Competitive Long-Term Investments Analysis
Latest Figures & CAGR of Competitors
Company | Long-Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ADC Therapeutics SA
NYSE:ADCT
|
Long-Term Investments
$1.6m
|
CAGR 3-Years
-67%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
AC Immune SA
NASDAQ:ACIU
|
Long-Term Investments
CHf361k
|
CAGR 3-Years
6%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Long-Term Investments
$2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Long-Term Investments
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Idorsia Ltd
SIX:IDIA
|
Long-Term Investments
CHf0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Kuros Biosciences AG
SIX:KURN
|
Long-Term Investments
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is ADC Therapeutics SA's Long-Term Investments?
Long-Term Investments
1.6m
USD
Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Long-Term Investments amounts to 1.6m USD.
What is ADC Therapeutics SA's Long-Term Investments growth rate?
Long-Term Investments CAGR 3Y
-67%
Over the last year, the Long-Term Investments growth was -95%. The average annual Long-Term Investments growth rates for ADC Therapeutics SA have been -67% over the past three years .